Head and neck carcinoma of unknown primary.


Journal

European annals of otorhinolaryngology, head and neck diseases
ISSN: 1879-730X
Titre abrégé: Eur Ann Otorhinolaryngol Head Neck Dis
Pays: France
ID NLM: 101531465

Informations de publication

Date de publication:
Jun 2019
Historique:
pubmed: 22 4 2019
medline: 27 12 2019
entrez: 22 4 2019
Statut: ppublish

Résumé

In adult cervicofacial pathology, carcinoma of unknown primary is defined as lymph-node metastasis the anatomic origin of which is not known at the time of initial management. It constitutes up to 5% of head and neck cancers. Presentation may suggest benign pathology, delaying and confusing oncologic treatment. Diagnostic strategy in cervical lymph node with suspicion of neoplasia requires exhaustive work-up to diagnose malignancy and, in 45% to 80% of cases, depending on the series, to identify the primary site. Histologic types comprise squamous cell carcinoma, thyroid carcinoma, adenocarcinoma, neuroendocrine carcinoma and undifferentiated carcinoma. Association is sometimes found with human papilloma virus or Epstein Barr virus, guiding treatment. The objective of the present study was to provide clinicians with the necessary diagnostic tools, based on the current state of clinical, imaging and pathologic knowledge, and to detail treatment options.

Identifiants

pubmed: 31005456
pii: S1879-7296(19)30062-6
doi: 10.1016/j.anorl.2019.04.002
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

185-192

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

T Kennel (T)

Département d'orl et chirurgie cervico faciale, hôpital universitaire Gui de Chauliac, université de Montpellier, CHRU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France.

R Garrel (R)

Département d'orl et chirurgie cervico faciale, hôpital universitaire Gui de Chauliac, université de Montpellier, CHRU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France. Electronic address: r-garrel@chu-montpellier.fr.

V Costes (V)

Département de biopathologie cellulaire et tissulaire des tumeurs, équipe médicale anatomie et cytologie pathologiques, hôpital universitaire Gui-de-Chauliac, université de Montpellier, CHRU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France.

P Boisselier (P)

Département de radiothérapie, institut du cancer de Montpellier, 208, avenue des Apothicaires, 34298 Montpellier, France.

L Crampette (L)

Département d'orl et chirurgie cervico faciale, hôpital universitaire Gui de Chauliac, université de Montpellier, CHRU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France.

V Favier (V)

Département d'orl et chirurgie cervico faciale, hôpital universitaire Gui de Chauliac, université de Montpellier, CHRU de Montpellier, 80, avenue Augustin-Fliche, 34295 Montpellier cedex 5, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH